| Identification | Back Directory | [Name]
UP 202-56 | [CAS]
163838-04-8 | [Synonyms]
UP 202-56
β-D-Ribofuranuronamide, N-cyclopropyl-1-deoxy-1-[6-[[2-[1-[(2,5-dimethylphenyl)methyl]-5-methyl-1H-indol-3-yl]ethyl]amino]-9H-purin-9-yl]- | [Molecular Formula]
C33H37N7O4 | [MDL Number]
MFCD00951250 | [MOL File]
163838-04-8.mol | [Molecular Weight]
595.7 |
| Hazard Information | Back Directory | [Uses]
UP202-56 is an adenosine analogue, which is an adenosinergic agonist. | [References]
[1] Honoré P, et al. UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. Pain. 1998 Apr;75(2-3):281-93. DOI:10.1016/s0304-3959(98)00006-2
[2] Camborde, Francois, et al. PHARMACEUTICAL COMBINATION WITH ANALGESIC ACTIVITY, CONTAINING AN ADENOSINERGIC AGONIST AND A COMPOUND SELECTED FROM OPIATES, BENZODIAZEPINES AND NMDA ANTAGONISTS. Patent Application WO/1999/029347. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|